Advertisement
Screener

ASPIRE BIOPHARMA HOLDINGS, INC. (ASBP) Return on Tangible Equity

2.8 / 5 stars · 68/120 Roast Me

ASPIRE BIOPHARMA HOLDINGS, INC. (ASBP) Return on Tangible Equity

  • 2026-06-30: Return Tang Equity -93.97%.
  • 2026-03-31: Return Tang Equity -304.06%.
  • 2025-12-31: Return Tang Equity 383.93%.
  • 2025-09-30: Return Tang Equity 179.11%.

Complete source-backed return tang equity history.

Available history
2022-06-30 to 2026-06-30
Data captured

Historical Return Tang Equity

DateReturn Tang Equity
2026-06-30-93.97%
2026-03-31-304.06%
2025-12-31383.93%
2025-09-30179.11%
2025-06-30196.58%
2025-03-31214.02%
2024-12-3185.05%
2024-09-3089.76%
2024-06-3098.20%
2024-03-31-277.83%
2023-12-31-915.03%
2023-09-30-10873.25%
2023-06-303052.71%
2023-03-31-61.39%
2022-12-31-33.61%
2022-09-30-11.38%
2022-06-30-0.16%

Annual Return Tang Equity

DateReturn Tang Equity
2025-12-31383.93%
2024-12-3185.05%
2023-12-31-915.03%
2022-12-31-33.61%

Similar stocks

Stock NameCountryMarket CapPE Ratio
BIOVIE INC. (BIVI)United States$0.012B
Tempest Therapeutics, Inc. (TPST)United States$0.013B
ADIAL PHARMACEUTICALS, INC. (ADIL)United States$0.012B
Phio Pharmaceuticals Corp. (PHIO)United States$0.012B-0.92
AEON Biopharma, Inc. (AEON)United States$0.013B-0.36
Scienture Holdings, Inc. (SCNX)United States$0.012B-0.38
MUSTANG BIO, INC. (MBIO)United States$0.013B
Vistagen Therapeutics, Inc. (VTGN)United States$0.013B-0.14
KIORA PHARMACEUTICALS INC (KPRX)United States$0.012B
Dare Bioscience, Inc. (DARE)United States$0.011B